Seeing Is Believing
FATE is currently covered by 4 analysts with an average price target of $6.58. This is a potential upside of $8.9 (180%) from yesterday's end of day stock price of $2.35.
Fate Therapeutics's activity chart (see below) currently has 140 price targets and 124 ratings on display. The stock rating distribution of FATE is 50% HOLD and 50% BUY.
Analysts average stock forecasts to be materialized ratio is 53.58% with an average time for these price targets to be met of 123 days.
Highest price target for FATE is $8, Lowest price target is $3.5, average price target is $6.58.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 14-Aug-2026.
Currently out of the existing stock ratings of FATE, 3 are a HOLD (50%), 3 are a BUY (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Aug-2024
$8
$5.69 (246.32%)
$6
1 months 1 days ago
(14-Aug-2026)
20/25 (80%)
$5.43 (211.28%)
240
Hold Since 27-Mar-2023
$3.5
$1.19 (51.52%)
$2.5
1 months 1 days ago
(14-Aug-2026)
3/5 (60%)
$0.93 (36.19%)
129
Buy Since 04-May-2026
$7
$4.9 (233.33%)
$7
3 months 7 days ago
(08-Jun-2026)
0/7 (0%)
$5.09 (266.49%)
Hold Since 27-Feb-2024
$7
$4.9 (233.33%)
$5
10 months 19 days ago
(27-Oct-2025)
11/16 (68.75%)
$5.45 (351.61%)
142
Buy Since 12-Mar-2020
$7
$4.9 (233.33%)
1 years 12 days ago
(03-Sep-2025)
1/4 (25%)
$6 (600.00%)
36
What is FATE (Fate Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on FATE (Fate Therapeutics)?
Which analyst has the most public recommendations on FATE (Fate Therapeutics)?
Which analyst is the currently most bullish on FATE (Fate Therapeutics)?
Which analyst is the currently most reserved on FATE (Fate Therapeutics)?